Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219829 · ClinicalTrials.gov registry record
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 5
- Enrollment target
NCT01219829 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 5 participants.
The verdict
NCT01219829 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The research purpose of this project is to create a registry, and blood and tissue bank for individuals at high-risk for pancreatic cancer. We plan to conduct histopathological and molecular analysis of resected pancreatic tissue prospectively collected from a cohort of pancreatic cancer patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-03-18 |
| Est. Completion | 2021-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01219829
The ClinicalTrials.gov registry entry for NCT01219829 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01219829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01219829 about?
NCT01219829 is a clinical study titled "Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma". The research purpose of this project is to create a registry, and blood and tissue bank for individuals at high-risk for pancreatic cancer. We plan to conduct histopathological and molecular analysis of resected pancreatic tissue prospectively collected from a cohort of pancreatic cancer patients.
What is the current status of trial NCT01219829?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2009-03-18. Estimated completion is 2021-04-27.
Who is sponsoring clinical trial NCT01219829?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.